NI
Nicox S.A.
NICXF · OTC
$0.30 +0.00% (+$0.00)
Market Cap 24.6M €
P/E Ratio -
Div. Yield -
ROE 438.40%
Bulios Fair Price
$0.26
13.3% downside
Trenutna cena
$0.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NICXF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
33 /100
Expensive P/S 3.12x
P/B 7.20x
P/E N/A
Growth
5 /100
Declining Rev. growth 2.90%
Book val. growth 64.39%
EPS growth N/A
Profitability
22 /100
Weak Gross margin 85.88%
FCF margin 0.00%
Net margin 284.90%
Quality
4 /100
Poor ROIC 46.51%
Asset turnover 0.32x
ROE 438.40%
Debt
50 /100
Moderate Debt/Equity 5.20x
Net debt/EBITDA -0.35x
Current ratio 6.63x
Stability
45 /100
Moderate Beta 0.52x
Profitable years 0
Rev. volatility 36.72%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NICXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gavin Spencer
Employees
10
Headquarters
Biot
Prihajajoči dogodki
03 MAR.
Earnings
Upcoming earnings report